PharmiWeb.com - Global Pharma News & Resources

Conference - Events

As clinical trials get increasingly complex, and outsourcing becomes more prevalent, the number of groups and individuals interacting with TMF widens. Now is the time to drive the industry toward a unified clinical model defined by end-to-end processes and systems, seamless collaboration among stakeholders, and greater insights across the clinical lifecycle. The Operationalize: eTMF Summit is the first of its kind to unite clinical trial sponsors, CROs, and sites to focus on how technology can be operationalized to break down silos and improve integration and collaboration. In turn, you'll learn how overall TMF health and sponsor oversight can be enhanced to improve inspection readiness. Join us this August, for over 20 case studies and interactive sessions designed to put a stop to ineffi…
Operationalize: Electronic Trial Master Files
The 2nd Annual Next Generation Cancer Vaccine Development Summit returns as the only industry-dedicated meeting bringing you the most up-to-date clinical and commercial developments utilizing next-generation vaccines for solid tumours and other cancers. Why have we failed in the past and how can we succeed in the future? By deciphering the challenges of antigen selection, point mutations, delivery, and resistance mechanisms, the 2nd Next Generation Cancer Vaccine Development Summit will focus on overcoming the translational and clinical challenges of therapeutic and prophylactic vaccines for oncology indications. Gain access to fresh studies and discussions covering ‘Personalized vs Off-the-Shelf’, shared neoantigens, immuno-stimulating adjuvants, understanding the tumour microenvironment,…
Next Generation Cancer Vaccine Development 2022
22-Aug-2022 - 24-Aug-2022
We are proud to host Cambridge Healthtech Institute's Fourteenth Annual Next Generation Dx Summit which will take place in-person at the Grand Hyatt Washington, D.C. on August 22-24. The Next Generation Dx Summit is the nexus for key opinion leaders across the world to share recent progress in diagnostic advancement and technology innovation. The event provides a valuable window on how point-of-care, infectious disease, liquid biopsy and companion diagnostics are changing the standard of care. Now in its fourteenth year, the Next Generation Dx Summit is a must-attend event with complete coverage of the most timely and important topics for the industry.
Join Your Analytical Community in London in 2022! The inaugural Cell Therapy Analytical Development Summit Europe is the leading industry-defining forum in Europe made exclusively for analytical, CMC, QC, process development and regulatory experts. Next generation cell therapies are emerging as game changing treatments for cancer and beyond, but given their increasing complexities, developing robust, reliable, and in-depth analytical assays is critical to prove their safety and quality to the regulatory authorities. This year we have unrivalled content showcasing: • Efforts to harmonise reference standards for state-of-the-art analytical development• Regulatory experience case studies to hit guidelines and avoid pushback• Strategies to develop a successful potency assay to determine produc…
Cell Therapy Analytical Development Summit Europe
2nd Annual Pharma Innovation Tech Congress 2022 “AI, IoT, Blockchain, Big Data & Digitalisation for Pharma” 25th August 2022, Hotel Kohinoor Continental, Mumbai, India   Join our new break-out sessions to deep dive into industry-specific Pharma Innovation Tech and explore real use cases and lessons learned by our customers.   DELEGATE REGISTRATION:   Please contact me on KAVITHA at Email: kavitha@virtueinsight.co.in or Call: +91 9361957193 / +91 44 24762472 Early Bird Price (Vailid until 11th Jully 2022) - INR 10,000 + GST(18%) per delegate Standard Price (Vailid from 12th Jully 2022)- INR 15,000 + GST(18%) per delegate Conference Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest and queries to kavitha@virtueinsight.co.in KEY SPEK…
29-Aug-2022 - 01-Sep-2022
With two approved therapeutics and the field working to develop the next generation of IPF drugs, the opportunity to become the undisputed, most effective, and disease-modifying agent on the market has never been greater. Packed with 4 days of insightful content, the IPF Summit is back in Boston to help you delve into the persistent translational and clinical challenges in the space. This industry’s undisputed forum will unite 150+ industry giants and pioneering academics in-person including Boehringer Ingelheim, Genentech, Novartis, AbbVie, Gilead, Fernando Martinez, Naftali Kaminski, Toby Maher, and many more. Join them to gain end-to-end insights to empower you with the knowledge you need for your 2022/2023 IPF research and drug development goals. Organizations across autoimmunity, rege…
6th IPF Summit 2022
29-Aug-2022 - 31-Aug-2022
With knowledge of brain barrier biology, precise modelling, and shuttle technologies accelerating at a rapid rate there has never been a more pivotal time in CNS therapeutics. The historic challenges of crossing the blood-brain-barrier present a key problem on the brink of solution with the recent critical approval in Japan by JCR Pharmaceuticals. At the 4th Brain Barriers Summit, you will join industry experts in this discursive, resolution led forum aiming to answer the question: how can we get neurological drugs to target? Navigating through translational concerns, pharmacodynamics and pharmacokinetics, quantifying barrier penetration, this meeting seeks to improve outcome measures as more and more companies are progressing their pipeline. At this summit you will meet and network with t…
4th Brain Barriers Summit
The inaugural Oligos & Peptides Formulation & Process Development Summit is the industry’s first forum bringing together experts addressing challenges and seek solutions to help to expedite drug discovery to scalable, GMP manufacturing for this new frontier of medicines! Recently, Biogen’s announcement of $60m upfront investment on a new antisense candidate from Ionis, and Janssen’s strategic collaboration with i2O Therapeutics for macromolecules, demonstrated drug developers’ interest in next generation complex oligonucleotides and peptides have reached unprecedented level. With the emergence of liquid phase synthesis technologies, improved bioavailability, and delivery approaches of oligos and peptides, drug developers realize the therapeutic potential of this 2nd generation of m…
Oligos & Peptides Formulation & Process Development
Magnus Group is pleased to invite you to its “2nd Edition of Global Conference on Agriculture and Horticulture” (Agri 2022) which will be scheduled during the month of September 01-03, 2022 with both virtual and in-person versions at Paris, France. The congress will revolve around the theme “Rethinking Paradigm Shift in Agriculture and Initiatives to Enhance Food Security.” The prime objective of Agri 2022 is to give worldwide participants the opportunity to share their ideas and experiences in person with their peers who are expected to come from all over the world. Furthermore, the plenary talks, keynote sessions, oral and poster presentations will assist delegates in establishing research or business relationships, as well as establishing international linkages for future collaborations…
2nd Edition of Global Conference on Agriculture and Horticulture
05-Sep-2022 - 06-Sep-2022
Conference series takes pleasure in inviting the scientific community across the globe to attend the 33rd European Pediatrics Conference during September 05-06, 2022 at Berlin, Germany with a motto to Fostering New Advancements in Ameliorating Child Health
33rd European Pediatrics Conference
We all know that decentralized clinical trials offer a plethora of advantages to trial participants and sponsors. What we don’t know is how to simplify regulatory understanding, streamline internal protocols, restructure recruitment processes, improve patient communication and address all the other operational challenges preventing us from fully capitalizing on this moment. That’s why each year DCT pioneers from pharma, CROs, tech providers and patient advocacy groups gather at the annual Operationalize: Decentralized Clinical Trials Summit to share lessons learned and best practice case studies to move the industry forward. This September, join over 150 DCT leaders to hear exclusive case-studies and engage in open discussions offering practical, implementable, and grounded insights. With…
3rd Operationalize: Decentralized Clinical Trials
07-Sep-2022 - 08-Sep-2022
Intelligent Health AI will once again bring together the global AI and health community in Basel this September to advance discussions on how AI can be used to prevent and solve some of the world’s greatest healthcare problems, and improve the health of the human race.
Magnus Group cordially invites you to attend its flagship event “4th Edition of Global Conference on Pediatrics and Neonatology (EPN 2022)” which will be held virtually and at Paris, France during the month of September 08-09, 2022. The congress will be centred around the theme “Promoting Excellence by Investigating the Unexplored Areas of Pediatrics and Neonatology.” Through plenary lectures, invited talks, keynote forums, symposiums, oral and e-poster presentations, product demonstrations, and hands-on practice, this global congress provides attendees with knowledge and skills to meet their professional goals. The two-day global summit allows conference goers to learn new techniques and the most recent breakthroughs in neonatal and paediatrics from researchers, scientists, academicians,…
4th Edition of Global Conference on Pediatrics and Neonatology
09-Sep-2022 - 10-Sep-2022
Episirus Scientifica welcomes you to attend 2022 World Pediatrics Conference (2022WPC) to be held during September 09-10, 2022 at Bangkok, Thailand around the theme “Current Challenges in Delivering Pediatric and Neonatal Researches” accredited with CPD credits which enable the professionals from worldwide to exchange their views on a wide variety of topics affecting child care and those suffering from pediatric diseases around the world. Since Genetic variance, developmental issues and Congenital defects are of a greater concern to pediatricians, we will be exploring more into these fields. This international meet (2022WPC) anticipates hundreds of participants including keynote speakers, Oral presentations by renowned speakers and poster presenters besides delegates around the world. This…
Join our Prestigious International Conference on  Experimental and Clinical Pharmacology and Toxicology at London UK (Hybrid Event)during September 12-13, 2022
Magnus Group is delighted to welcome you all to the “Euro Global Conference on Proteomics, Genomics and Bioinformatics” (EURO PROTEOMICS) which will take place in a hybrid manner at Paris, France and virtually from September 12-13, 2022. The congress will emphasize the theme “Envisioning the Future and Exploring All Facets of Proteomics, Genomics and Bioinformatics.” This global summit will show appreciation to the tireless efforts of protein experts, genomics specialists, researchers, scientists, academicians, bioinformaticians, healthcare practitioners, and clinicians to address the challenges by focusing on the most recent advances and innovations in proteomics, genomics and bioinformatics to enable more powerful analytics for translational research toward better health and disease inte…
The 3rd Annual Gene Therapy for Ophthalmic Disorders meeting is bringing you even more world class content, bringing you two tracks of learning to tackle the pressing challenges faced in the pre-clinical stages and in clinical development. This includes challenges faces with drug targets including wet AMD, dry AMD, DME, IRDs and more. Join 40+ speakers from the industry leaders in ophthalmic gene therapy such as: Adverum, REGENXBIO, Novartis, Janssen, Kriya, Nanoscope, IVERIC, GenSight, SparingVision, Atsena, AGTC, ViGeneron and many more as we discover novel vector engineering, disease models, clinical trials design, patient enrolment platforms and more. This year an additional day to compliment the scientific program has been added. The NEW hotly anticipated post-conference delivery day…
3rd Gene Therapy for Ophthalmic Disorders 2022
Skin microbiome research is continuing to gain increasing market traction from a number of stakeholders, including drug developers and cosmetic brands. For investment and progress to continue, it is vital to meet and connect with the key opinion leaders in the space. Now in its fifth year, the Microbiome Movement – Skin Health & Dermatology Summit will unite the field’s leaders from academia and industry to address the unique scientific and commercial challenges of working in the skin microbiome. This meeting will provide a platform for crucial discussions which will hasten the development of microbiome-targeting therapeutics and cosmetics that focus on characterization, clinical testing, and product commercialization. This is your opportunity to connect with 100+ collaborative thought…
Microbiome Movement Skin Health & Dermatology Summit | September 13-15 | Boston, MA
13-Sep-2022 - 14-Sep-2022
The medical device market is constantly evolving and given the complexity of the market drivers and contractants, the solution is to build agility into the business with strong commitments to new product development, while maintaining and existing product lines. However, the pandemic has had a huge impact on medical devices such as rethinking our digital strategies, engaging customers, and adapting to working remotely while virtually engaging consumers and telehealth options. As we see things going back to normal while moving forward from COVID-19, there are major setbacks medical device marketers have to worry about as well such as supply chain shortages, the minimal adoption of invasive devices, wearable technology, and the rise of outsourcing. It is important at the conference which wil…
Re:Imagine Medical Device Marketing
14-Sep-2022 - 15-Sep-2022
The “new normal” after more than two years of no face-to-face interaction is upon us. MSLs as a primary field position now are having the opportunity to go back to the field and connect with KOLs while keeping the virtual tools to engage. Entering the hybrid world to be able to successfully engage with HCPs in their preferred ways.Therefore, the role of the MSL is evolving and MSLs are being required to wear more hats than ever before. The involvement in different aspects of the lifecycle while providing value and maintaining compliant interactions with commercial and with KOLs.The 2nd MSL Best Practices Summit will focus on the Evolution of the role, the right use of metrics and the value they need to have when it comes to measuring the MSL function, involvement in clinical trials, KOL en…
2nd MSL Best Practices